Chemical Structure (Zioptan 01)
Zioptan Solution/ Drops
Product Images NDC 82584-609
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zioptan (NDC 82584-609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Thea Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure A (Zioptan 02)
Figure B (Zioptan 03)
Figure C (Zioptan 04)
Figure D (Zioptan 05)
Principal Display Panel (0.3 mL Container Pouch Carton)
ZIOPTAN® is a prescription medication containing tafluprost for ophthalmic use in the eye. It comes in the form of a single-use container with no preservatives and must be kept refrigerated between 2 and 8°C. The medication contains glycerol, sodium dihydrogen phosphate dihydrate, disodium edetate, polysorbate 80, and water with hydrochloric acid or sodium hydroxide to adjust pH. This medication is for topical application only in the eyes. The description of additional information is not available due to quality.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
